BWC Ohio’s Nick Trego PharmD, State Fund of California’s Chief Medical Officer Dinesh Govindarao MD, Washington L&I Medical Director Gary Franklin MD MPH, and Sedgwick Pharmacy Director Paul Peak all documented significant reductions in long-term opioid usage in their patient populations.
That means many fewer moms without kids, husbands without wives, and kids without grandparents.
Among the takeaways:
Prevention is critical – We’re doing a very good job of preventing more Opioid Abuse Disorder (OAD) patients.
Flexible treatment options are critical – Every patient is different, with some responding to Medication-Assisted Therapy and others not. The same is true for exercise, yoga, cognitive behavioral therapy, acupuncture, and PT.
Closed physician networks, formularies and UR with teeth are critical – It’s tough to get bad docs to become good ones, so kicking them out of your panel is necessary.
Analytics are critical – To identify patients at risk of OAD, to monitor progress, to evaluate success, to learn what works and what doesn’t and why.
Full payer access to Prescription Drug Monitoring Programs is critical – But only available in a handful of states. Access to PDMPs that require physician usage would go a long way to reducing inappropriate prescribing and polypharmacy.
Results – Across the board we heard of dramatic reductions in the volume and potency of scripts prescribed and the number of patients taking opioids over the long term.
What does this mean for you?
It can be done, it is being done, and it must be done!